Diagnostics company BioPorto proposes a prominent biotech profile and former CEO of the company Symphogen as a new member of its board of directors, to be officially elected at its general meeting in April.
BY ELIZABETH MØNSTED JOHANSEN Offentliggjort 20.03.17 kl. 11:46
Log ind for at læse artikler
Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.
Sharing product-related news on the social media LinkedIn had consequences for an employee in the Danish unit of MSD. The post could be regarded as advertisement and has resulted in a fine from The Ethical Committee for the Pharmaceutical Industry.
The Swedish company Ascelia, managed by a former Sunstone director, has acquired the biotech company Oncoral and its cancer candidate, which is currently being tested in phase I trials at Herlev Hospital in Denmark.
The world’s largest hearing device dealer, Amplifon, expresses concern over the entry into the retail market of manufacturers such as William Demant. GN Resound, on the other hand, receives praise and is expected to form even closer ties to its Italian collaborator.
The Danish biotech company Gubra has announced a collaboration with a major German drug group for the development of novel peptide compounds. The deal has a potential value of EUR 250 million or approximately DKK 2 billion.
An artificial pancreas system from a US-based medtech group that Zealand Pharma and Novo Nordisk have both partnered with is approaching its first regulatory approvals in the coming years following a successful study with a candidate drug from Zealand, says CEO Ed Damiano in an interview with MedWatch.
Amerikanske Juno Therapeutics vil sælge nye aktier og i yderste instans rejse, hvad der svarer til små 2 mia. kr. Samtidig er man rykket i et nyt hovedkvarter forud for en forventet godkendelse af sin CAR-T-cellebehandling til næste år.
Produktions-problemerne på en fransk fabrik vil kun have en meget begrænset effekt på ALK's forretning og kan ikke sidestilles med den franske Rival Stallergenes' produktionskvaler i 2016, siger adm. direktør Carsten Hellmann. Det danske selskab er allerede i gang med en omfattende opgradering af kvalitetskontrol og compliance i sit globale produktionsapparat.